The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.
This report broadly segments the atherectomy devices market into product, application, end user, and region. On the basis of product, the market is categorized into directional, photo-ablative (laser), orbital, rotational atherectomy systems, and support devices. In 2017, the directional atherectomy devices segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technology advancements in the field of directional atherectomy.
Based on application, the atherectomy devices market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the largest share of the market and is expected to be the fastest growing segment during the forecast period. The large share of this segment is attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment and rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries.
Download PDF Brochure: https://www.marketsandmarkets.com/requestsample.asp?id=133112140
Based on end user, the atherectomy devices market is segmented into three categories, namely, hospitals and surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment accounted for the largest share of the market due to the increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment and growing availability of healthcare reimbursements across major countries.
This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.
Factors such as stringent regulatory framework, significant adoption of alternative therapies, and dearth of well-trained surgeons to conduct atherectomy procedures are expected to restrain the growth of the atherectomy devices market during the forecast period.
The major players in the atherectomy devices market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
No comments:
Post a Comment